The big question
Aromatase inhibitors are pills that lower estrogen to help keep hormone-sensitive breast cancer from coming back. They work well, but they often cause joint pain and stiffness, and that pain can lead people to stop taking them as prescribed. Can acupuncture help, and does the benefit last?
What they did
The trial included 226 women with early-stage breast cancer at 11 US sites. All were taking an aromatase inhibitor and had joint pain of at least 3 on a 0 to 10 scale. They were randomly assigned to real acupuncture, sham (fake) acupuncture, or a waiting list. Acupuncture was given twice a week for 6 weeks, then weekly for 6 more weeks. Pain was measured at 52 weeks.
What they found
At one year, which was 40 weeks after acupuncture ended, people who got real acupuncture had worst-pain scores about 1 point lower on the 0 to 10 scale than either the sham or waiting-list groups. Pain also got in the way of daily life less than in the sham group. Most participants (84.5%) completed the trial.
Why it matters
Joint pain is a common reason people struggle with these important medicines. A non-drug option with lasting benefit could help people stay on treatment.
What it doesn't mean
The improvement was modest, about 1 point. Most participants (87.7%) were White, so results may differ in other groups. Acupuncture is a support, not a replacement for your cancer medicine.
Read the original abstract+
Importance: Aromatase inhibitors (AIs) have proven efficacy for the treatment of hormone-sensitive breast cancer; however, arthralgias (pain and stiffness) contribute to nonadherence with therapy for more than 50% of patients. Objective: To examine the effect of acupuncture in reducing AI-related joint pain through 52 weeks. Design, Setting, and Participants: A randomized clinical trial was conducted at 11 sites in the US from May 1, 2012, to February 29, 2016, with a scheduled final date of follow-up of September 5, 2017, to compare true acupuncture (TA) with sham acupuncture (SA) or waiting list control (WC). Women with early-stage breast cancer were eligible if they were taking an AI and scored 3 or higher on the Brief Pain Inventory Worst Pain (BPI-WP) item (score range, 0-10; higher scores indicate greater pain). Analysis was conducted for data received through May 3, 2021. Interventions: Participants were randomized 2:1:1 to the TA (n = 110), SA (n = 59), or WC (n = 57) group. The TA and SA protocols were composed of 6 weeks of intervention at 2 sessions per week (12 sessions overall), followed by 6 additional weeks of intervention with 1 session per week. Participants randomized to WC received no intervention. All participants were offered 10 acupuncture sessions to be used between weeks 24 and 52. Main Outcomes and Measures: In this long-term evaluation, the primary end point was the 52-week BPI-WP score, compared by study group using linear regression, adjusted for baseline pain and stratification factors. Results: Among 226 randomized women (mean [SD] age, 60.7 [8.6] years; 87.7% White; mean [SD] baseline BPI-WP score, 6.7 [1.5]), 191 (84.5%) completed the trial. In a linear regression, 52-week mean BPI-WP scores were 1.08 (95% CI, 0.24-1.91) points lower in the TA compared with the SA group (P = .01) and were 0.99 (95% CI, 0.12-1.86) points lower in the TA compared with the WC group (P = .03). In addition, 52-week BPI pain interference scores were statistically significantly lower in the TA compared with the SA group (difference, 0.58; 95% CI, 0.00-1.16; P = .05). Between 24 and 52 weeks, 12 (13.2%) of TA, 6 (11.3%) of SA, and 5 (10.6%) of WC patients reported receipt of acupuncture. Conclusions and Relevance: In this randomized clinical trial, women with AI-related joint pain receiving 12 weeks of TA had reduced pain at 52 weeks compared with controls, suggesting long-term benefits of this therapy. Trial Registration: ClinicalTrials.gov Identifier: NCT01535066
Abstract reproduced from Hershman DL et al., JAMA Network Open (2022), under a CC BY 4.0 license. Plain-English summary by Womanhattan.
This summary was written with AI assistance and checked against the original paper. It is for learning, not medical advice. Talk with your care team before changing anything about your health or treatment.